DEC 05, 2019 5:00 AM PST

The clinical implications of high sensitive assays for HBsAg

Sponsored by: Abbott
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Medical Director, Infectious Diseases - Abbott Diagnostics
    Biography
      Born in Roma (Italy), February 10th,1956. Medical degree "cum laude" July 1980. Specialty in Gastrointestinal Diseases, July 1984. PhD in Infectious Diseases, July 1988. Associate Director Medical & Scientific Affairs, at Abbott Diagnostics with global responsibility for Infectious Diseases. Member of Italian and European Associations for the Study of the Liver (AISF, EASL); European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Italian Society of Virology (ISV/SIV); Italian Blood Transfusion Society (SIMTI); European Society of Cardiology (ESC); American Association for Clinical Chemistry (AACC).

      Main research activities in Infectious Diseases: development and validation of an off-label procedure for human immunodeficiency virus (HIV) antibody avidity as a tool for identifying recent infections; clinical usefulness of hepatitis C virus core antigen (HCVAg) in diagnosis and monitoring, including health economic perspectives; quantitative serological biomarkers for hepatitis B virus (HBV) infection. Author or coauthor of 234 scientific papers, of which 73 on international, peer-reviewed journals, and about 25 congress proceedings. Adjunct professor ("Sapienza" University of Roma) at postgraduate schools in Clinical Microbiology (years 1994-1999) and Clinical Pathology (1997 and 2001-2007). Seminars on infectious diseases diagnosis at the National Institute of Health (Roma, Italy) in 1996 and 2002-2003.

    Abstract
    DATE:  December 5, 2019
    TIME:   5:00am PST, 8:00am EST
     
    The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Over the decades the sensitivity of HBsAg assays has increased, and the most recent solutions attain a level of 5 mIU/mL and enable to detect active HBV also at very low level of expression, with HBV-DNA levels <100 mIU/mL. The availability of such assays will help improve the safety of blood screening in settings that do not encompass testing for HBV-DNA and will enable unveiling HBsAg in a substantial share of "occult" or "latent" HBV infections (OBI). Unveiling OBIs has a great clinical relevance in immunocompromised or immunosuppressed patients and in people coinfected by other viruses, such as HCV or HIV. Additionally, since the negativity for HBsAg is a major endpoint for antiviral treatment with nucleosi(t)ide analogues, a higher sensitivity for HBsAg can help with a safer interruption of treatment.
     
    Learning Objectives:
    • Review the natural history of HBV infection and the progress in HBsAg testing
    • Understand the mechanism and clinical implications of HBV reactivation
    • Acknowledge the medical improvements linked to a better sensitivity for HBsAg
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    DEC 05, 2019 5:00 AM PST

    The clinical implications of high sensitive assays for HBsAg

    Sponsored by: Abbott
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Laboratory Testing

    Infectious Disease

    Immunology

    Clinical Diagnostics

    Microbiology

    Molecular Diagnostics

    Molecular Biology

    Clinical Chemistry

    Biochemistry

    Diagnostics

    Cancer Diagnostics

    Biomarkers

    Clinical Research

    Pcr/rt-Pcr/real-Time Pcr

    Cancer Research

    Geography

    North America44%

    Europe31%

    Asia15%

    South America4%

    Africa3%

    Oceania2%

    Registration Source

    Website Visitors48%

    Email Promotions15%

    WAVE Newsletter Promotion6%

    Trending Newsletter Promotion2%

    Social Media Promotions1%

    Other28%

    Job Title

    Medical Laboratory Technician25%

    Facility/Department Manager15%

    Clinical Laboratory Scientist11%

    Lab Management10%

    Executive6%

    Medical Doctor/Specialist6%

    Student4%

    Scientist4%

    Educator/Faculty4%

    Marketing/Sales3%

    Consultant2%

    Chemist2%

    Biologist2%

    Research Scientist2%

    Microbiologist2%

    Other3%

    Organization

    Clinical Laboratory21%

    Hospital20%

    Diagnostic Company9%

    Academic Institution9%

    Medical Device Company6%

    Biotech Company4%

    Industrial Company3%

    Medical Center3%

    Life Science Company2%

    Pharmaceutical Company2%

    Distribution/sales2%

    General Laboratory2%

    Government2%

    Independent Laboratories1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources